[Purpose, Case, and Methods] A female bottlenose dolphin (Tursiops truncatus) in captivity developed necrosis of the tail flukes. Although the diseased site healed after surgical resection, the loss of approximately 75% of the tail greatly affected her swimming performance. To restore swimming ability, we developed artificial tail flukes as a prosthetic swimming aid and provided physical therapy that included swimming training from postoperative day 1 to day 1427. [Results] The prosthetic enabled the dolphin to recover swimming ability almost to the level prior to disease onset, but even acquire applied movement, and reestablish social relationships, thus greatly improving the animal's quality of life. [Conclusion] The results clearly demonstrate that, as in postoperative rehabilitation in humans, the use of prosthetic devices in physical therapy can be beneficial for marine animals such as dolphins.

Paracoccidioidomycosis ceti (PCM-C) is a chronic granulomatous keloidal dermatitis in cetaceans that has been reported worldwide and is caused by Paracoccidioides ceti. Serological cross-reactions among highly pathogenic fungal infections and related diseases have been reported. However, the true cross-reaction of antibodies against P. ceti has remained unknown due to the use of positive control sera from infected dolphins. This study aimed to re-evaluate antibodies from mechanically dislodged fungal cells in the infected tissue of a PCM-C case and demonstrate the actual cross-reaction. The results revealed a limited cross-reaction between PCM-C and paracoccidioidomycosis, while the antibodies did not react with other pathogens such as Coccidioides posadasii, Histoplasama capsulatum, and Arthrographis kalrae. Thus, the method for evaluation of the antibody against PCM-C is reliable, and there is potential for epidemiological study.

This exploratory study evaluated plasma atrial natriuretic peptide (ANP) concentrations in four species of captive cetaceans and their associations with physiological and environmental factors, including husbandry conditions, diet, and management practices. Twenty-six individuals were voluntarily sampled, and blood samples were analyzed using a human-based chemiluminescent immunoassay. Transthoracic echocardiography was also attempted in several individuals but was technically challenging due to interference from the lung tissue and the sternum. The mean plasma ANP concentration in clinically healthy young animals was 44.12 ± 14.62 pg/mL, with no significant differences observed according to age, sex, species, or the presence of mild chronic disease. ANP was detectable across all species using human reagents. In addition, brain natriuretic peptide (BNP), a commonly used cardiac biomarker in humans and other animals, was evaluated for comparison; however, BNP concentrations remained below the detection threshold, possibly reflecting species-specific differences. Importantly, ANP concentrations were not evaluated in animals with clinically significant disease, and therefore the relevance of these findings to diseased populations remains unknown. These results demonstrate that plasma ANP can be measured using existing clinical assays and provide preliminary baseline data for multiple cetacean species. Overall, ANP may offer preliminary insights into physiological variation in managed cetaceans; however, its utility as a biomarker for cardiovascular or systemic health assessment remains to be determined.